
GeneDx Faces Securities Class Action Lawsuit Over Misleading Disclosures
August 3 marks the final deadline for GeneDx Holdings Corp. shareholders to join a class action lawsuit alleging violations of the Securities Exchange Act. Investors who purchased WGS stock between April 16, 2025, and May 4, 2026, are now being urged to contact legal counsel regarding potential recovery of losses.






















